Literature DB >> 25524762

Abortion after deliberate Arthrotec® addition to food. Mass spectrometric detection of diclofenac, misoprostol acid, and their urinary metabolites.

Bernhard Watzer1, Klaas J Lusthof, Horst Schweer.   

Abstract

Arthrotec(®) (AT) is a combination of diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), and misoprostol (MP), a synthetic analogue of prostaglandin E1 (PGE1). MP is a lipophilic methyl ester prodrug. It is readily metabolized to the biologically active misoprostol acid (MPA). During the last few years, medical studies exhibited MP to be an excellent abortive. In this paper, we describe a rare criminal case of MP abortion, initiated by the expectant father. After the abortion, samples of vomit and urine were collected. Systemic exposure to MP is difficult to prove, because both MP and the active metabolite MPA are hardly excreted in urine. Therefore, in addition to routine toxicological analysis, we used slightly modified, well-established liquid and gas chromatographic/tandem mass spectrometric (LC/MS/MS and GC/MS/MS) methods, for the direct and the indirect detection of MPA and its metabolites. In this case, we were able to demonstrate the presence of the major MP metabolites 2,3-dinor-MPA and 2,3,4,5-tetranor-MPA in the urine of the victim. We also detected paracetamol, 3-methoxyparacetamol and diclofenac-glucuronide in the urine. In the vomit of the victim, we detected diclofenac and MPA. These results, combined with the criminal investigations, showed that the accused had mixed MP into the food of his pregnant girlfriend. Finally, these investigations contributed to a confession of the accused.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25524762     DOI: 10.1007/s00414-014-1136-4

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  27 in total

1.  Absorption kinetics of misoprostol with oral or vaginal administration.

Authors:  M Zieman; S K Fong; N L Benowitz; D Banskter; P D Darney
Journal:  Obstet Gynecol       Date:  1997-07       Impact factor: 7.661

2.  Pharmacokinetics of different routes of administration of misoprostol.

Authors:  Oi Shan Tang; Horst Schweer; H W Seyberth; Sharon W H Lee; Pak Chung Ho
Journal:  Hum Reprod       Date:  2002-02       Impact factor: 6.918

3.  Toxicological analysis of whole blood samples by means of Bond-Elut Certify columns and gas chromatography with nitrogen-phosphorus detection.

Authors:  P G Zweipfenning; A H Wilderink; P Horsthuis; J P Franke; R A de Zeeuw
Journal:  J Chromatogr A       Date:  1994-07-15       Impact factor: 4.759

4.  A randomized comparison of pharmacokinetics of a single vaginal dose of dry misoprostol or misoprostol moistened with normal saline or with acetic acid.

Authors:  Vivian Chi Yan Lee; Sofie Shuk Fei Yung; Raymond Hang Wun Li; Bernhard Watzer; Horst Schweer; Ernest Hung Yu Ng; Pak Chung Ho
Journal:  Hum Reprod       Date:  2011-09-09       Impact factor: 6.918

5.  Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.

Authors:  A Aronsson; C Fiala; O Stephansson; F Granath; B Watzer; H Schweer; K Gemzell-Danielsson
Journal:  Hum Reprod       Date:  2007-05-08       Impact factor: 6.918

6.  Misoprostol and illegal abortion in Rio de Janeiro, Brazil.

Authors:  S H Costa; M P Vessey
Journal:  Lancet       Date:  1993-05-15       Impact factor: 79.321

Review 7.  The metabolism of diclofenac--enzymology and toxicology perspectives.

Authors:  Wei Tang
Journal:  Curr Drug Metab       Date:  2003-08       Impact factor: 3.731

8.  The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration.

Authors:  Hany Abdel-Aleem; José Villar; A Metin Gülmezoglu; Sayed A Mostafa; Alaa A Youssef; Mahmoud Shokry; Bernhard Watzer
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-05-01       Impact factor: 2.435

9.  Metabolism and pharmacokinetic studies of misoprostol.

Authors:  G Schoenhard; J Oppermann; F E Kohn
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

Review 10.  Overview of the mucosal protective effects of misoprostol in man.

Authors:  E Z Dajani
Journal:  Prostaglandins       Date:  1987
View more
  3 in total

1.  Medical abortions among university students in Ghana: implications for reproductive health education and management.

Authors:  Nana Nimo Appiah-Agyekum
Journal:  Int J Womens Health       Date:  2018-09-05

2.  Diclofenac Concentrations in Post-Mortem Specimens-Distribution, Case Reports, and Validated Method (UHPLC-QqQ-MS/MS) for Its Determination.

Authors:  Paweł Szpot; Olga Wachełko; Marcin Zawadzki
Journal:  Toxics       Date:  2022-07-26

Review 3.  Forensic Toxicological Aspects of Misoprostol Use in Pharmacological Abortions.

Authors:  Paweł Szpot; Olga Wachełko; Marcin Zawadzki
Journal:  Molecules       Date:  2022-10-03       Impact factor: 4.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.